In-Vitro Fertilization Market (By Product Type: Fresh Donor, Fresh Non-Donor, Frozen Donor, and Frozen Non-Donor; By End User: Fertility Clinics, Surgical Centers, Hospitals, and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023– 2032
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on In-Vitro Fertilization Market
5.1. COVID-19 Landscape: In-Vitro Fertilization Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global In-Vitro Fertilization Market, By Product
8.1. In-Vitro Fertilization Market, by Product Type, 2023-2032
8.1.1. Fresh Donor
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Fresh Non-Donor
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Frozen Donor
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Frozen Non-Donor
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global In-Vitro Fertilization Market, By End User
9.1. In-Vitro Fertilization Market, by End User, 2023-2032
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Surgical Centers
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Hospitals
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Research Institutes
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global In-Vitro Fertilization Market, By Instrument
10.1. In-Vitro Fertilization Market, by Instrument, 2023-2032
10.1.1. Culture Media
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Disposable Devices
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Capital Equipment
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global In-Vitro Fertilization Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by End User (2020-2032)
11.1.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by End User (2020-2032)
11.2.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by End User (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by End User (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by End User (2020-2032)
11.3.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by End User (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by End User (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by End User (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by End User (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by End User (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Instrument (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by End User (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Instrument (2020-2032)
Chapter 12. Company Profiles
12.1. AmbroiseParé Group
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Amedes MVZ Cologne GmbH
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AMP Center St Roch
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AVA Clinic Scanfert
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bangkok IVF Center
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bangkok IVF center
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Betamedics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Biofertility Center
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bloom Fertility and Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Bloom Fertility Center
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bourn Hall Fertility Center
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample